3.23.1 html 166 246 1 false 51 0 false 9 false false R1.htm 0000001 - Document - Cover Sheet http://c4therapeutics.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://c4therapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statements of Stockholders??? Equity Sheet http://c4therapeutics.com/role/CondensedConsolidatedStatementsofStockholdersEquity Condensed Consolidated Statements of Stockholders??? Equity Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://c4therapeutics.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Disclosure - Nature of the business and basis of presentation Sheet http://c4therapeutics.com/role/Natureofthebusinessandbasisofpresentation Nature of the business and basis of presentation Notes 7 false false R8.htm 0000008 - Disclosure - Summary of significant accounting policies Sheet http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies Summary of significant accounting policies Notes 8 false false R9.htm 0000009 - Disclosure - Fair value measurements Sheet http://c4therapeutics.com/role/Fairvaluemeasurements Fair value measurements Notes 9 false false R10.htm 0000010 - Disclosure - Marketable securities Sheet http://c4therapeutics.com/role/Marketablesecurities Marketable securities Notes 10 false false R11.htm 0000011 - Disclosure - Property and equipment Sheet http://c4therapeutics.com/role/Propertyandequipment Property and equipment Notes 11 false false R12.htm 0000012 - Disclosure - Leases Sheet http://c4therapeutics.com/role/Leases Leases Notes 12 false false R13.htm 0000013 - Disclosure - Accrued expenses and other current liabilities Sheet http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities Accrued expenses and other current liabilities Notes 13 false false R14.htm 0000014 - Disclosure - Collaboration and license agreements Sheet http://c4therapeutics.com/role/Collaborationandlicenseagreements Collaboration and license agreements Notes 14 false false R15.htm 0000015 - Disclosure - Long-term debt ??? related party Sheet http://c4therapeutics.com/role/Longtermdebtrelatedparty Long-term debt ??? related party Notes 15 false false R16.htm 0000016 - Disclosure - Stock-based compensation Sheet http://c4therapeutics.com/role/Stockbasedcompensation Stock-based compensation Notes 16 false false R17.htm 0000017 - Disclosure - Commitment and contingencies Sheet http://c4therapeutics.com/role/Commitmentandcontingencies Commitment and contingencies Notes 17 false false R18.htm 0000018 - Disclosure - Loss per share Sheet http://c4therapeutics.com/role/Losspershare Loss per share Notes 18 false false R19.htm 0000019 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies Summary of significant accounting policies (Policies) Policies 19 false false R20.htm 0000020 - Disclosure - Fair value measurements (Tables) Sheet http://c4therapeutics.com/role/FairvaluemeasurementsTables Fair value measurements (Tables) Tables http://c4therapeutics.com/role/Fairvaluemeasurements 20 false false R21.htm 0000021 - Disclosure - Marketable securities (Tables) Sheet http://c4therapeutics.com/role/MarketablesecuritiesTables Marketable securities (Tables) Tables http://c4therapeutics.com/role/Marketablesecurities 21 false false R22.htm 0000022 - Disclosure - Property and equipment (Tables) Sheet http://c4therapeutics.com/role/PropertyandequipmentTables Property and equipment (Tables) Tables http://c4therapeutics.com/role/Propertyandequipment 22 false false R23.htm 0000023 - Disclosure - Accrued expenses and other current liabilities (Tables) Sheet http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables Accrued expenses and other current liabilities (Tables) Tables http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities 23 false false R24.htm 0000024 - Disclosure - Collaboration and license agreements (Tables) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables Collaboration and license agreements (Tables) Tables http://c4therapeutics.com/role/Collaborationandlicenseagreements 24 false false R25.htm 0000025 - Disclosure - Long-term debt ??? related party (Tables) Sheet http://c4therapeutics.com/role/LongtermdebtrelatedpartyTables Long-term debt ??? related party (Tables) Tables http://c4therapeutics.com/role/Longtermdebtrelatedparty 25 false false R26.htm 0000026 - Disclosure - Stock-based compensation (Tables) Sheet http://c4therapeutics.com/role/StockbasedcompensationTables Stock-based compensation (Tables) Tables http://c4therapeutics.com/role/Stockbasedcompensation 26 false false R27.htm 0000027 - Disclosure - Loss per share (Tables) Sheet http://c4therapeutics.com/role/LosspershareTables Loss per share (Tables) Tables http://c4therapeutics.com/role/Losspershare 27 false false R28.htm 0000028 - Disclosure - Nature of the business and basis of presentation (Details) Sheet http://c4therapeutics.com/role/NatureofthebusinessandbasisofpresentationDetails Nature of the business and basis of presentation (Details) Details http://c4therapeutics.com/role/Natureofthebusinessandbasisofpresentation 28 false false R29.htm 0000029 - Disclosure - Fair value measurements (Details) Sheet http://c4therapeutics.com/role/FairvaluemeasurementsDetails Fair value measurements (Details) Details http://c4therapeutics.com/role/FairvaluemeasurementsTables 29 false false R30.htm 0000030 - Disclosure - Marketable securities - Summary of marketable securities (Details) Sheet http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails Marketable securities - Summary of marketable securities (Details) Details 30 false false R31.htm 0000031 - Disclosure - Marketable securities - Summary of marketable securities in unrealized loss position (Details) Sheet http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails Marketable securities - Summary of marketable securities in unrealized loss position (Details) Details 31 false false R32.htm 0000032 - Disclosure - Marketable securities - Narrative (Details) Sheet http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails Marketable securities - Narrative (Details) Details 32 false false R33.htm 0000033 - Disclosure - Property and equipment (Details) Sheet http://c4therapeutics.com/role/PropertyandequipmentDetails Property and equipment (Details) Details http://c4therapeutics.com/role/PropertyandequipmentTables 33 false false R34.htm 0000034 - Disclosure - Accrued expenses and other current liabilities (Details) Sheet http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails Accrued expenses and other current liabilities (Details) Details http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables 34 false false R35.htm 0000035 - Disclosure - Collaboration and license agreements - Narrative (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails Collaboration and license agreements - Narrative (Details) Details 35 false false R36.htm 0000036 - Disclosure - Collaboration and license agreements - Summary of allocation of transaction price (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsSummaryofallocationoftransactionpriceDetails Collaboration and license agreements - Summary of allocation of transaction price (Details) Details 36 false false R37.htm 0000037 - Disclosure - Collaboration and license agreements - Schedule of revenue from collaboration agreements (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails Collaboration and license agreements - Schedule of revenue from collaboration agreements (Details) Details 37 false false R38.htm 0000038 - Disclosure - Collaboration and license agreements - Schedule of financial information related to collaboration and license agreements (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails Collaboration and license agreements - Schedule of financial information related to collaboration and license agreements (Details) Details 38 false false R39.htm 0000039 - Disclosure - Collaboration and license agreements - Schedule of supplemental financial information related to collaboration and license agreements (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails Collaboration and license agreements - Schedule of supplemental financial information related to collaboration and license agreements (Details) Details 39 false false R40.htm 0000040 - Disclosure - Long-term debt ??? related party - Schedule of long-term debt (Details) Sheet http://c4therapeutics.com/role/LongtermdebtrelatedpartyScheduleoflongtermdebtDetails Long-term debt ??? related party - Schedule of long-term debt (Details) Details 40 false false R41.htm 0000041 - Disclosure - Long-term debt ??? related party - Narrative (Details) Sheet http://c4therapeutics.com/role/LongtermdebtrelatedpartyNarrativeDetails Long-term debt ??? related party - Narrative (Details) Details 41 false false R42.htm 0000042 - Disclosure - Long-term debt ??? related party - Summary of future minimum payments (Details) Sheet http://c4therapeutics.com/role/LongtermdebtrelatedpartySummaryoffutureminimumpaymentsDetails Long-term debt ??? related party - Summary of future minimum payments (Details) Details 42 false false R43.htm 0000043 - Disclosure - Stock-based compensation - Schedule of stock-based compensation expense (Details) Sheet http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails Stock-based compensation - Schedule of stock-based compensation expense (Details) Details 43 false false R44.htm 0000044 - Disclosure - Stock-based compensation - Narrative (Details) Sheet http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails Stock-based compensation - Narrative (Details) Details 44 false false R45.htm 0000045 - Disclosure - Stock-based compensation - Summary of RSU activity (Details) Sheet http://c4therapeutics.com/role/StockbasedcompensationSummaryofRSUactivityDetails Stock-based compensation - Summary of RSU activity (Details) Details 45 false false R46.htm 0000046 - Disclosure - Loss per share - Schedule of diluted net loss per share attributable to common stockholders (Details) Sheet http://c4therapeutics.com/role/LosspershareScheduleofdilutednetlosspershareattributabletocommonstockholdersDetails Loss per share - Schedule of diluted net loss per share attributable to common stockholders (Details) Details 46 false false R47.htm 0000047 - Disclosure - Loss per share - Schedule of basic and diluted loss per share (Details) Sheet http://c4therapeutics.com/role/LosspershareScheduleofbasicanddilutedlosspershareDetails Loss per share - Schedule of basic and diluted loss per share (Details) Details 47 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cccc-20230331.htm 4 cccc-20230331.htm cccc-20230331.xsd cccc-20230331_cal.xml cccc-20230331_def.xml cccc-20230331_lab.xml cccc-20230331_pre.xml cccc-20230331xexx311.htm cccc-20230331xexx312.htm cccc-20230331xexx321.htm cccc-20230331xexx322.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true